UCB - Ebitda





Ebitda Veränderung Datum
Alcon AG USD 795M 478M 2026-03
Almirall EUR 114.07M 60.37M 2025-12
Amarin USD 12.54M 28.57M 2025-06
argenx SE USD 427M 22.88M 2026-03
AstraZeneca USD 5.67B 1.29B 2026-03
Bayer EUR 4.45B 2.49B 2026-03
Genmab DKK 186M 291M 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
GRIFOLS EUR 347.45M 210K 2025-12
Hikma Pharmaceutical USD 369M 84M 2024-12
Lakefront Biotherapeutics EUR -63.7M 624.2M 2026-03
Lonza CHF 1.01B 54M 2025-12
Merck EUR 1.53B 87M 2026-03
Novartis USD 6.48B 1.19B 2026-06
Orion EUR 191.9M 61.5M 2026-06
Recordati EUR 283.58M 36.43M 2026-03
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 3.31B 3.65B 2026-03
UCB EUR 1.6B 570M 2025-12
Unibail Rodamco EUR 1.02B 71.7M 2024-12